Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found that those taking GLP-1 drugs, a…

Continue Reading

News Source: www.sciencedaily.com